JWD Subscribe to eTOC alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Journal of Wildlife Diseases, 38(1), 2002, pp. 27-31
© Wildlife Disease Association  2002
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kreeger, T.
Right arrow Articles by Olsen, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kreeger, T.
Right arrow Articles by Olsen, S.

Brucella abortus strain RB51 vaccination in elk. II. Failure of high dosage to prevent abortion

TJ Kreeger, WE Cook, WH Edwards, PH Elzer, and SC Olsen


ABSTRACT

Brucella abortus strain RB51 is used as a vaccine because it induces antibodies that do not react on standard serologic tests for brucellosis allowing differentiation between vaccination and infection. Strain RB51 was evaluated in captive elk (Cervus elaphus) to determine if vaccination protected against abortion following experimental challenge. Thirty elk were vaccinated intramuscularly with 1.0 x 10(10) colony-forming units (CFU) of strain RB51 in March 1998. Fourteen of these were given a booster dose of 1.13 x 10(10) CFU exactly 1 yr later. All vaccinated elk seroconverted via a modified dot blot assay to strain RB51 with the booster group having higher titers (P < or = 0.001). Seventeen other elk served as unvaccinated controls. All elk were bred and determined pregnant using pregnancy-specific protein B analysis. Elk were challenged in March 2000 with 1.1 x 10(7) CFU of B. abortus strain 2308 administered intraconjunctivally and all elk seroconverted to strain 2308. Fifteen of 17 control elk aborted; 16 of 16 elk given a single vaccination aborted (P = 0.44); and 13 of 14 elk given a booster aborted (P = 0.86). There were two viable calves in the control group and one in the booster group. Strain 2308 was recovered from fetuses and nonviable calves in all groups. Based on the results of this and other studies, the use of strain RB51 to prevent abortion in elk cannot be recommended.


This article has been cited by other articles:


Home page
 Clin. Microbiol. Rev.Home page
E. N. T. Meeusen, J. Walker, A. Peters, P.-P. Pastoret, and G. Jungersen
Current Status of Veterinary Vaccines
Clin. Microbiol. Rev., July 1, 2007; 20(3): 489 - 510.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
S. C. Olsen, S. J. Fach, M. V. Palmer, R. E. Sacco, W. C. Stoffregen, and W. R. Waters
Immune Responses of Elk to Initial and Booster Vaccinations with Brucella abortus Strain RB51 or 19
Clin. Vaccine Immunol., October 1, 2006; 13(10): 1098 - 1103.
[Abstract] [Full Text] [PDF]

Home page
 J Wildl DisHome page
T. J. Kreeger, W. E. Cook, W. H. Edwards, and T. Cornish
Brucellosis in Captive Rocky Mountain Bighorn Sheep (Ovis canadensis) Caused by Brucella abortus Biovar 4
J. Wildl. Dis., April 1, 2004; 40(2): 311 - 315.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Wildlife Disease Association.